NYSE:CPHI China Pharma (CPHI) Stock Price, News & Analysis → CBOE shift unlocks new weekend income strategy (From DTI) (Ad) Free CPHI Stock Alerts $0.37 -0.06 (-13.11%) (As of 10:03 AM ET) Add Compare Share Share Today's Range$0.36▼$0.4150-Day Range$0.34▼$0.5552-Week Range$0.32▼$2.70Volume47,383 shsAverage Volume375,352 shsMarket Capitalization$2.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Get China Pharma alerts: Email Address Ad DTIthe most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here About China Pharma Stock (NYSE:CPHI)China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. The company also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. It offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. The company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.Read More CPHI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPHI Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comStockNews.com Begins Coverage on China Pharma (NYSE:CPHI)March 22, 2024 | morningstar.comChina Pharma Holding IncMarch 28, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…March 19, 2024 | americanbankingnews.comChina Pharma (NYSE:CPHI) Research Coverage Started at StockNews.comMarch 14, 2024 | msn.comChina Healthcare Stocks Rally on Hopes for Govt SupportMarch 14, 2024 | msn.comChina Healthcare Stocks Rally on Hopes for Govt SupportMarch 11, 2024 | tmcnet.comRising Demand for Secure Packaging Solutions and Enhanced Aesthetic Appeal Propels Market to US$ 432.1M by 2034 | Future Market Insights, Inc.March 6, 2024 | finance.yahoo.comChina Pharma Holdings, Inc. (CPHI)March 28, 2024 | Behind the Markets (Ad)The Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.February 27, 2024 | benzinga.comChina Pharma Holding Stock (AMEX:CPHI), Insider Trading ActivityFebruary 27, 2024 | benzinga.comChina Pharma Holding Stock (AMEX:CPHI), Guidance and ForecastFebruary 24, 2024 | finanznachrichten.deChina Pharma Holdings, Inc.: China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitFebruary 23, 2024 | prnewswire.comChina Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitFebruary 9, 2024 | markets.businessinsider.comChina Pharma Holdings Issues 15M Unregistered SharesFebruary 9, 2024 | msn.comChina Pharma Holdings Acquires Psoriasis Patent and Profit DealFebruary 6, 2024 | msn.comScoop: China panel plans biotech field hearingFebruary 6, 2024 | axios.comExclusive: China panel eyes biotech field hearingJanuary 23, 2024 | investing.comChina SXT Pharmaceuticals Inc (SXTC)January 23, 2024 | wsj.comChina Pharma Holdings Inc.November 29, 2023 | msn.comChina’s new cancer drug is approved in the US but will cost 30 times moreNovember 29, 2023 | finance.yahoo.comChina Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceNovember 29, 2023 | finance.yahoo.comChina Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceNovember 21, 2023 | msn.comAnother top executive is being investigated by China’s corruption watchdogNovember 8, 2023 | markets.businessinsider.comCASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPANovember 7, 2023 | markets.businessinsider.comKexing Biopharm Attended CPHI Worldwide 2023November 2, 2023 | markets.businessinsider.comXinhua Silk Road: 54th Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's JiangxiOctober 25, 2023 | msn.comIndia to witness the fastest growth rate in biologicals in next 5 years, CHPISee More Headlines Receive CPHI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/15/2018Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSE:CPHI CUSIPN/A CIK1106644 Webwww.chinapharmaholdings.com Phone8689866811730Fax86-898-6681-9024Employees234Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,970,000.00 Net Margins-39.99% Pretax Margin-39.99% Return on Equity-64.09% Return on Assets-18.81% Debt Debt-to-Equity Ratio0.23 Current Ratio0.82 Quick Ratio0.29 Sales & Book Value Annual Sales$7.78 million Price / Sales0.32 Cash FlowN/A Price / Cash FlowN/A Book Value$2.86 per share Price / Book0.13Miscellaneous Outstanding Shares6,590,000Free Float3,559,000Market Cap$2.50 million OptionableNot Optionable Beta0.91 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMs. Zhilin Li (Age 71)President, CEO, Chairman & Interim CFO Comp: $241.6kMs. Huang Na C.F.A.BOD Secretary & IR ManagerKey CompetitorsAgile TherapeuticsNASDAQ:AGRXCNS PharmaceuticalsNASDAQ:CNSPTenon MedicalNASDAQ:TNONLucy Scientific DiscoveryNASDAQ:LSDIReShape LifesciencesNASDAQ:RSLSView All Competitors CPHI Stock Analysis - Frequently Asked Questions How have CPHI shares performed in 2024? China Pharma's stock was trading at $0.6050 at the start of the year. Since then, CPHI stock has decreased by 36.6% and is now trading at $0.3833. View the best growth stocks for 2024 here. How were China Pharma's earnings last quarter? China Pharma Holdings, Inc. (NYSE:CPHI) announced its quarterly earnings data on Wednesday, August, 15th. The company reported ($1.00) EPS for the quarter. The company earned $3.17 million during the quarter. China Pharma had a negative trailing twelve-month return on equity of 64.09% and a negative net margin of 39.99%. When did China Pharma's stock split? Shares of China Pharma reverse split on Wednesday, March 6th 2024. The 1-5 reverse split was announced on Wednesday, March 6th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 6th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. What other stocks do shareholders of China Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other China Pharma investors own include iShares Silver Trust (SLV), Check-Cap (CHEK), ContraFect (CFRX), Clear Channel Outdoor (CCO), Boxlight (BOXL), Bionano Genomics (BNGO), Athersys (ATHX), Assertio (ASRT), AMC Entertainment (AMC). How do I buy shares of China Pharma? Shares of CPHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CPHI) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.